Renascience Pharma Limited

Renascience Pharma Ltd from Slough UK: small company, active status, founded 10 years ago, £578,539 assets, real address, 4 directors, no owners. Regular importer of pharmaceutical products (3 months imported). It’s a small, family-run business with an active trading status. Founded ten years ago, the company employs no people and holds £578,539 in assets. With a real registered address and four directors at the helm, it’s a tight-knit operation. The firm regularly imports pharmaceutical products, with 3 months of import activity recorded, the latest in November 2022.

While Renascience Pharma Ltd’s core business involves the manufacture of basic pharmaceutical products, its website reveals a focus on paediatric medicine. Founded with the goal of improving treatment options within rare paediatric diseases, the company’s lead project aims to establish a new era in neuroblastoma treatment. It’s even partnered with Essential Pharma, an international specialty pharma group, and has licensed technology from St. Jude Children’s Hospital. The company is clearly aiming to carve out a niche in the pharmaceutical market, with blog content reinforcing its expertise in rare disease therapies.

Financially, Renascience Pharma Ltd shows mixed signals. Current assets increased by 45% to £580,000, while net assets decreased by 19% to £250,000. Bank borrowings surged by 230%, reaching £340,000, and cash reserves fell 42% to £350,000. On the upside, creditors decreased by 18%, suggesting better debt management. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) helps it stay agile, but the equity drop raises questions. With no auditor mentioned (likely exempt as a small company), the figures rely on unaudited statements.

In short, Renascience Pharma Ltd is holding steady but facing pressures. Its focus on paediatric medicine and partnership with Essential Pharma offer potential for growth—a contrast to the more modest financial performance. Whether it can sustain its growth trajectory remains to be seen.

Registered in England/Wales under the registration number 09420886, with a registered address at SL1 2BE, United Kingdom, Slough, Berkshire, The Urban Building Second Floor, 3-9 Albert Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.